Genotype–phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran

ADVERSE EFFECTS OF HYDROXYUREA IN β-THALASSEMIA INTERMEDIA PATIENTS: 10 Years’ Experience

(2010) Mehran Karimi et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Response to hydroxyurea in β thalassemia major and intermedia: Experience in western India

(2009) Khushnooma Y. Italia et al.   CLINICA CHIMICA ACTA

Hydroxyurea in the Management of Thalassemia Intermedia

(2009) Mehran Karimi   HEMOGLOBIN

HYDROXYUREA-INDUCED HEMATOLOGICAL RESPONSE IN TRANSFUSION-INDEPENDENT BETA-THALASSEMIA INTERMEDIA: Case Series and Review of Literature

(2009) Mohammad Ali Ehsani et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Response to hydroxyurea therapy in β-thalassemia

(2008) Ariel Koren et al.   AMERICAN JOURNAL OF HEMATOLOGY

Prevalence of β-Thalassemia Trait and Glucose-6-Phosphate Dehydrogenase Deficiency in Iranian Jews

(2007) Mehran Karimi et al.   ARCHIVES OF MEDICAL RESEARCH